SOP Lithiumaugmentation

Benjamin Ochs; Tom Bschor

doi:10.1055/s-0043-112884

PSYCH up2date, Inhaltsverzeichnis

PSYCH up2date 2017; 11(04): 293-297
DOI: 10.1055/s-0043-112884

SOP / Arbeitsablauf

Georg Thieme Verlag KG Stuttgart · New York

SOP Lithiumaugmentation

Benjamin Ochs

,

Tom Bschor

Abstract

Alle Artikel dieser Rubrik

Lithiumaugmentation ist eine additive, gut evaluierte Therapiemethode zur Behandlung akuter Depressionen. Sie wird für Patienten eingesetzt, die auf einen Therapieversuch mit einem Antidepressivum nicht angesprochen haben.

Volltext

Referenzen

Literatur
1 Burgess S, Geddes J, Hawton K. et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001; (03) CD003013
2 Severus E, Taylor MJ, Sauer C. et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014;
3 Bauer M, Crossley NA, Gerber S, Bschor T. The Acute Antidepressive Effects of Lithium: From Monotherapy to Augmentation Therapy in Major Depression. In: Bauer M, Grof P, Müller-Oerlinghausen B. eds. Lithium in Neuropsychiatry. The Comprehensive Guide. London: Informa healthcare; 2006: 109-127
4 Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 2007; 68: 935-940
5 Nelson JC, Baumann P, Delucchi K. et al. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression. J Affect Disord 2014; 168: 269-275
6 DGPPN, BÄK, KBV, AWMF, Hrsg. für die Leitliniengruppe Unipolare Depression*. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression-Langfassung. 2. Auflage. Version 5. 2015. http://www.depression.versorgungsleitlinien.de Stand: 10.04.2017 (* Organisationen, die in der Leitliniengruppe kooperierten: DGPPN, BÄK,KBV, AWMF, ACKPA, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, BDK, BDP, BPM, BVDN, BVDP, BVVP, CPKA, DÄVT, DFT, DGGPP, DGPT, DGVT, DPG, DPV, DPtV, DVT, GwG, Stiftung Deutsche Depressionshilfe)
7 Dé Montigny C, Grunberg F, Mayer A. et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981; 138: 252-256
8 Bschor T. Lithium in the treatment of major depressive disorder. Drugs 2014; 74: 855-862
9 Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 2003; 64 (Suppl. 05) 44-52
10 Cipriani A, Pretty H, Hawton K. et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162: 1805-1819
11 Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001; 104: 163-172
12 Bschor T, Bauer M. Is successful lithium augmentation limited to serotonergic antidepressants?. J Clin Psychopharmacol 2004; 24: 240-241
13 Bschor T, Berghöfer A, Ströhle A. et al. How long should the lithium augmentation strategy be maintained? A 1-year follow up of a placebo-controlled study in unipolar refractory major depression. J Clin Psychopharmacol 2002; 22: 427-430
14 Bauer M, Bschor T, Kunz D. et al. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 2000; 157: 1429-1435